Valeant Pharmaceuticals

Allergan Fined $15M Over Disclosure Failures
Ex-Valeant, Philidor Execs Accused of Kickback Scheme
Regulator Bars Valeant Officers From Trading
Ex-Valeant CFO Denies ‘Improper Conduct’
Valeant Stock Falls 10% on News of CEO’s Illness
Valeant to Take $150M Hit From Walgreens Deal
Activist Investor Can’t Dodge Insider Trading Suit
Zoetis Gives Back Post-Takeover Report Gains
Watchdogs Call for Shorter Window for Activist Disclosures
Salix Calls Off Tax Inversion Deal